• Sports performance medicine and nutrition is a strong focus for Neutra. As the company’s new Sports Performance Medical Advisor, Dr. Cherry will continue his recent work designing tailored medical programs and services focused on human performance.
• Neutra will aggressively target the promising sports nutrition market, a segment with sales that are currently expected to reach $11 billion by 2023.
• Neutra is developing third-party certified hemp-derived CBD health and nutritional product lines for consumers.
• Hemp-based CBD consumer projects generated sales of up to $390 million in 2018 with analysts predicting sales of hemp-based products could reach $22 billion by 2022.
• Leadership has a proven track record of adding value for public company shareholders.

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

• Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
• J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

• Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
• ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

For more information, visit the company’s website at www.NeutraInc.com

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR

• BacTech Environmental is an Ontario, Canada-based company that uses microbial bacteria for “bioleaching” the arsenic from historic and often-abandoned mine projects, leaving the sites environmentally restored and making their precious metals easier to process
• The company has attained equity interests in mine remediation projects in Bolivia and Ecuador, and it is working with Ontario’s Cambrian College to identify the “best bugs” to tackle the arsenic in those countries
• BacTech recently strengthened its financing with a two-tranche funding effort that’s expected to bring in $125,000

Environmental remediation at mine tailing sites has gained a natural, even holistic, advocate in the form of BacTech Environmental Corp. (CSE: BAC) (OTC: BCCEF), a Toronto-based “bioleaching” corporation that aims to put microbes to work in stabilizing dangerous arsenic mine waste and recovering more precious metals in the process.

“Our Bugs Eat Rocks,” one company video presentation declared in 2013 (http://ibn.fm/PjkJd). CEO and President Ross Orr explained in the video how BacTech’s proprietary technology was being primed for use in cleaning up tailings at the former Telamayu project in Bolivia – a mill that received ore for processing for nearly a century from various mines in the area until it was abandoned over 50 years ago.

The plan is to use naturally occurring bacteria to clean up sulfide tailings at such projects, he said.

“The tailings there (in Bolivia) have been oxidizing for some time and releasing acid mine drainage into the local river, which of course goes right into the town of Atocha next door,” Orr added.

Orr issued a call for funding the cleanup project through the medium of the video, a request that has been repeated a number of times since. Last month, BacTech announced its most recent success in obtaining capital to advance its bioleaching project, referring to a two-tranche private placement financing effort that’s expected to bring in $125,000 (http://ibn.fm/ZOj1S).

A second BacTech project involves the potential use of bioleach processing to treat historic arsenopyrite concentrates and tailings produced in Southern Ecuador by small mom-and-pop operations. Environmental microbiologist Nadia Mykytczuk has been working with BacTech to identify the best bacteria for the region’s needs and the ideal conditions for nurturing their growth inside fermentation tanks where the arsenic is stabilized even as precious metals are recovered. A research project has also grown out of the Ecuadorean reclamation effort, including a test facility with bioreactors at Cambrian College in Sudbury, near Toronto, according to publication Northern Ontario Business (http://ibn.fm/7LDgx).

“We’ve completed a year’s worth of test work to find the best bugs, under the best conditions, to extract the gold out of this high arsenic material,” Mykytczuk told Northern Ontario Business. “If you take a handful of tailings from Copper Cliff or Ecuador you have thousands to millions of individual organisms, and that diversity matters because those bugs are best adapted to those conditions. Nature knows best. It will have picked bugs that can grow in a particular situation. My goal is to demonstrate that we can use this technology to reprocess the many thousands of abandoned mines here that still hold a lot of value.”

BacTech Environmental’s strategy includes seeking an equity position in each remediation project it undertakes and augmenting related revenues with additional cash flow proceeding from metal recovery. Where possible, the company will also pursue governmental and non-governmental organization (NGO) funding for the projects.

The company notes that its strategy is based on the global demand for cleaning up mining areas as world populations become ever-more environmentally conscious, as well as the potential revenue stream resulting from the interest in remediation, as opposed to simple revenues from licensing the bioleaching technology to other firms for their uses.

For more information, visit the company’s website at www.BacTechGreen.com

• Sonic Automotive ranks among the top five retail automotive groups in the United States each year, as reported by industry publication Automotive News
• The company has a new vehicle-centered retail division and its EchoPark Automotive used car division, both focused on innovations to the buying experience
• During the second quarter, EchoPark’s sales grew by 68.7 percent as new vehicle sales volume slowed
• Despite a downturn in new vehicle sales during the quarter, Sonic’s total sales established a number of consolidated all-time quarterly records

Innovative automotive retailer Sonic Automotive Inc. (NYSE: SAH) is a Fortune 500 company that consistently ranks among the top five largest retail automotive groups in the United States, growing from a small business with 20 stores in 1997 to a group of more than 100 stores selling 24 brands currently.

Sonic was one of seven U.S. retailers to report over 100,000 new vehicle sales last year, rising to just shy of 300,000 units sold when used and wholesale transactions were factored in. Total revenues for the group were $9.95 billion (http://ibn.fm/lW9NF).

Under the company’s One Sonic One Experience campaign, introduced in 2014, non-commissioned sales representatives work with shoppers over the course of about an hour to make buying a vehicle an enjoyable experience by “eliminating all the pain points” that can accompany identifying the right vehicle and subsequent negotiations. The company’s priority on transparency extends from the service area to trade-in valuations, and it purchases consumers’ vehicles without trade-in requirements.

Sonic’s EchoPark Automotive segment is the corporate arm that deals in used cars and light trucks, helping to arrange additional finance and insurance product sales in eight specialty retail locations across North Carolina, Texas and Colorado.

EchoPark’s retail sales topped 12,500 vehicles during the second quarter of 2019, marking an increase of 68.7 percent from the previous year’s second quarter.

“Even as the new vehicle market started showing signs of weakness (during the second quarter), we still had record results in our pre-owned and F&I business lines and grew our fixed operations by 6.4 percent,” CEO David Smith stated in a company news release issued July 25 (http://ibn.fm/6Ma3u). “This, once again, shows how the dynamic dealer operating model benefits from multiple revenue streams. We are very excited to see the maturity of our current EchoPark locations as illustrated by our most mature market, Denver, Colorado… It is very exciting to see the results when you focus on the customer and use technology and process to reduce your expenses and simplify the operational model. We believe we will be able to open an additional EchoPark store before the end of 2019 and another shortly thereafter in the first half of 2020. Our current plans include two additional EchoPark store openings in the second half of 2020.”

EchoPark’s revenues of $291.7 million during the second quarter put the company on track to exceed $1.1 billion by year’s end, and Sonic’s total sales established a number of consolidated all-time quarterly records, according to the report. The company’s board of directors approved a quarterly dividend of $0.10 per share payable in cash for stockholders of record on September 13, 2019.

For more information, visit the company’s website at www.SonicAutomotive.com

• Trxade Group helps sustain independent pharmacies through its web-based purchasing platform, network of locally run pharmacies, data analytics and delivery services
• Independent pharmacists often find themselves at the forefront of the battle over health care costs, working to stay afloat as drug costs rise and insurer reimbursements fall
• The value of independent pharmacies lies in the sense of community that they have helped instill for decades among their patients, and, as the small businesses close their doors, they leave behind ‘pharmacy deserts’ bereft of close-to-home services
• Trxade Group reported record revenues of over $1.9 million in its second quarter filing through its services in support of independent pharmacies; its network of such pharmacies continues to grow

Independent, locally operated pharmacies have long been one of the most familiar ways of defining a community’s lifestyle. While their heyday may be decades in the past – an era when teens and adults alike sat on bar stools listening to the jukebox while sipping a soda or enjoying some ice cream – many small business entrepreneurs continue to stubbornly define their pride in their local neighborhoods by the traffic that comes through the family-owned pharmacies’ front doors.

Florida-based Trxade Group Inc. (OTCQB: TRXD), a pharmaceutical services network that has established its own community of trust, technology and transparency through a trademarked supplier-to-pharmacy (S2P) trading platform, is bringing the buyers and sellers of medicinal products and services together to support the locally minded independent businesses nationwide, helping them to identify the best available sourcing and pricing for prescription drugs.

A key challenge to the existence of independent pharmacies in the modern era is the capacity that larger drug store chains have for buying pharmaceutical products in bulk, thereby getting larger supplies at reduced costs. Those difficulties have been exacerbated as the pharmacy benefit managers (PBMs) designed to process claims for pharmacies have turned to working for Medicare, Medicaid and commercial health plans – their aim now to manage pharmaceutical benefits and keep insurers’ costs low (http://ibn.fm/CniN7).

A news media series of reports on ‘pharmacy deserts’ cropping up across Ohio and elsewhere in the United States (http://ibn.fm/11Fpk) as independent businesses close their doors expresses particular concern about the strain created by low reimbursement rates for state Medicaid patient coverage. Even many physicians are turning away potential patients over the state insurers’ record of poor reimbursement and complicated procedures for obtaining reimbursement (http://ibn.fm/sw932).

When the independent, locally owned businesses suffer, patients suffer as well. After the CVS network bought and closed the Lonsinger Pharmacy in Danville, Ohio, two years ago, the town’s librarian told The Columbis Dispatch (http://ibn.fm/Ysr0Q) that one elderly resident “broke down crying… He said, ‘I can’t walk to Mount Vernon’ (the nearest town where a pharmacy could now be found), but he could walk to Lonsinger’s.” When a Manchester, Connecticut, pharmacy sold its accounts to the national chain this month, one employee reminisced (http://ibn.fm/QvIiO) about how the local employees had “really gone the extra mile, gone to people’s homes, fixed (medicine) boxes, or helped with dosages. On our way home from closing our store at night we made deliveries.”

“That’s what’s good about independent pharmacies. The people that work here, we’re a family,” a former employee at a now-closed independent pharmacy in a Maryland town noted in an article published by The Baltimore Sun (http://ibn.fm/j3IwK).

Trxade Group is working to empower independently owned pharmacies and help them manage their operations through data analysis resources that note where a demand for their products is likely to occur and predictively pairs that information with data on product availability and costs.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Neutra Corp. is working to establish its position within the rapidly growing hemp-based product and CBD markets
• The company’s recent acquisition of J3 Holdings will give Neutra Corp. access to J3 Holdings’ land, warehouse and hemp cultivation license, allowing it to ensure the quality of ingredients used in product development
• Neutra Corp. also announced the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products that are third-party certified

Neutra Corp. (OTCQB: NTRR), an early stage research and development company focusing on modern healthy living solutions, recently announced a couple of important moves in line with its corporate expansion and vertical integration CBD market strategy.

On July 24, 2019, Neutra Corp. announced its entry into a letter of intent for the acquisition of J3 Holdings (http://ibn.fm/QIaX1), which currently owns land and a warehouse, as well as a license for hemp cultivation and refining into usable forms. Through the move, Neutra will become capable of cultivating, manufacturing and distributing hemp-based CBD products.

For some time, Neutra had been concentrating its efforts on the development of hemp-based CBD products. With the latest acquisition, it aims to become capable of growing its own hemp supply to ensure the quality of ingredients.

On July 26, Neutra Corp. announced another very important acquisition to strengthen its CBD market position even further (http://ibn.fm/kq4VM). The company signed a letter of intent for the acquisition of Vivis, an emerging retail brand of hemp-based health and nutritional products.

Vivis CBD products are third-party certified as containment-free and of consistent quality and potency, Neutra Corp. President Sydney Jim said in a news release. Consumers are becoming more interested in products that have such certification, which could increase the demand for Neutra products upon completion of the Vivis acquisition, he concluded.

Neutra is working to establish its position in the particularly lucrative CBD market. According to industry forecasts, hemp-based product sales could reach $22 billion by 2022. Several factors contribute to the growth, including rapid legalization, higher levels of consumer awareness and significantly more research being conducted into the health benefits of CBD.

The range of CBD products is constantly growing. Currently, it includes oils, creams, supplements, analgesics, beverages, edibles and various others. CBD can also be inhaled to deliver anti-depression benefits, anti-inflammatory effects, pain relief and relief from the symptoms of neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike other compounds, CBD does not cause addiction. It also avoids the typical high that stems from THC use.

According to Sydney Jim, the CBD market offers tremendous opportunities. This is the main reason why Neutra Corp. will continue targeting the sector moving forward, he concluded.

To cement its market position, Neutra Corp. has been actively looking for partners and acquisitions in the hemp-derived product niche for over eight months.

For more information, visit the company’s website at www.NutraInc.com

• Plans are already in place to expand Grapefruit’s state-of-the-art extraction facility
• The company is dedicated to distributing its own products and providing high-quality cannabis commodities to customers
• Grapefruit’s newest product demonstrates the company’s capabilities and serves as a flagship of its edibles line

Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), a fully licensed cannabis manufacturer and distributor in California, is fast becoming recognized in the industry for its quality product lines. Those products – including Rainbow Dreams, Grapefruit’s most recent offering – adhere strictly to the company’s motto and commitment to offer “a high you can trust.”

That commitment starts at the heart of the company’s operations – its fully licensed and compliant ethanol extraction laboratory located in the Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. Widely recognized as a hub for quality cannabis activity, the Coachillin’ location is the perfect backdrop for Grapefruit’s manufacturing and distribution operations.

Grapefruit began extraction in May and already has expansion plans in place that will allow the growing company to increase efficiencies and output. The company plans to build a state-of-the-art, all-inclusive facility that will house a 50,000-square-foot-plus indoor grow canopy and large extraction lab; a manufacturing space to produce its vape lines and CBD products; an FDA-certified kitchen for the production of Grapefruit edibles; and a distribution facility for selling all products throughout the entire cannabis marketplace. The new structure is expected to be built adjacent to the company’s current operations in the Coachillin’ park.

Grapefruit’s dedication to quality and service means that, in addition to being able to offer a large and diverse inventory of superior cannabis products that can be delivered within 24 hours of order, the company’s wholesale distribution arm will also offer high-quality, competitively priced raw materials to other manufacturers and distributors. Grapefruit’s extraction lab produces high-quality distillate or ‘honey oil’, a universal product used in everything from infused edibles and tinctures/creams to the ‘fuel’ used in vapes and e-cigarettes. Honey oil is a highly sought out item on the cannabis market, and Grapefruit’s commitment to premium quality ingredients will enable the company to demand top dollar for its cannabis products. Utilizing biomass cultivated in its own indoor grow canopy operation, Grapefruit aims to position itself for high revenue potential.

In addition to expanding its extraction lab, Grapefruit recently strengthened its position as a growing presence in the cannabis space with the launch of its newest brand, Rainbow Dreams, a unique line of newly formulated and flavored CBD- and THC-infused cannabis oil vaporization cartridges. Rainbow Dreams is made from the most trusted oils and highest-quality, authentic CCELL ceramic vaporizer cartridges, ensuring the most consistent and smooth product delivery available in the industry today. The four new Rainbow Dream vape cartridges each offer a unique flavor profile, including mango passion, citrus bliss, berry delight and strawberry ice.

“Moving the Rainbow Dreams project forward demonstrates our team’s ability to bring a high-quality product to market at a competitive price,” Grapefruit CEO Bradley J. Yourist stated in a news release (http://ibn.fm/gLj02). “Flavored and full-spectrum cannabis oils… are growing in popularity in California and elsewhere because customers in the recreational market want a no burn-flavored oil without any offending cannabis smell. Our Rainbow Dreams products deliver on this… It is our experience that some customers like a more CBD- and CBN-heavy formulated oil for help with pain and sleep.”

Yourist indicated that Rainbow Dreams will be the flagship for Grapefruit’s new cartridges, which are planned for release within the next 45 days.

“By implementing our own high-end, custom-formulated vaporization cartridge line, Grapefruit believes it will capture significant revenue opportunities as we move inexorably toward our goal of becoming a leading, fully integrated, licensed and compliant cannabis-product manufacturing and distribution company,” Yourist added.

Grapefruit holds California licenses to both manufacture and distribute cannabis products. The company’s vision is to become a seed-to-sale, fully vertically integrated, ethical and compliant cannabis and CBD product company. The company works to manufacture, procure and distribute only the highest-quality, all-natural cannabis honey oil, edibles, flowers, concentrates and related products that are free from pesticides, heavy metals and bacteria.

For more information, visit the company’s website at www.GrapefruitBlvd.com

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://ibn.fm/IGNG

• Health Canada is enforcing mandatory cannabis testing for the presence of pesticide active ingredients; unauthorized pesticide use can result in seizure or recall of product, suspension/revocation of licenses and penalties of up to $1 million
• MustGrow is seeking Health Canada approval for its patented biopesticide as a natural, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production
• A joint research and development program with the National Research Council Canada is underway, with a focus on the efficacy of MustGrow’s biopesticides for use in cannabis production
• MustGrow’s safe and effective natural products are EPA- and PRMA-approved and registered for use on fruits, vegetables, turf and ornamental crops

MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizer products for the cannabis industry, is continuing its joint research and development program with the National Research Council Canada (NRC). The NRC is an agency of the government of Canada whose research and development divisions are focused on supporting innovation efforts in key industry sectors, including the rapidly expanding cannabis marketplace (http://ibn.fm/gCar2).

MustGrow’s biopesticide R&D program with the NRC targets an issue plaguing licensed cannabis producers who must follow regulatory guidelines when it comes to using pesticides or pest control products (“PCP”) in growing and manufacturing cannabis products. Under the Cannabis Act, license holders may only use certain PCPs that have been approved for use on cannabis by the Pest Management and Regulatory Agency (http://ibn.fm/liqhz).

MustGrow and the NRC are conducting a series of efficacy assessments of MustGrow’s patented natural biopesticide as a natural pre-plant, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production (http://ibn.fm/T5jTD). MustGrow’s products are refined from compounds of the mustard plant, utilizing the plant’s natural defense mechanism as a pre-plant soil biopesticide treatment (http://ibn.fm/UAulS) and are shown to deliver effective pathogen and pest control to ensure plant growth and high yields in a variety of agricultural settings (http://ibn.fm/zsuSl).

Canada’s licensed producers (LPs) are required by law to demonstrate that no unauthorized pesticides were used on their products or contaminated them (http://ibn.fm/oo6wQ), and mandatory testing is underway to ensure that LPs comply. Failure of Health Canada’s sampling and testing program for unauthorized pest control products could result in product seizure or destruction, recall of products sold, suspension or revocation of the firm’s license, or a monetary penalty of up to C$1 million, according to Health Canada.

Through MustGrow’s eventual suite of biostimulant/biofertilizer offerings, Canadian cannabis license holders may have access to products that aid in the production of compliant, pest-free cannabis. MustGrow’s science-based suite of signature products have already demonstrated control of many soil-borne diseases and pests that affect cannabis production, including Botrytis (grey mold), Pythium root rot, Rhizoctonia fungus, Fusarium, nematodes, Verticillium wilt, Phytophthora root rot and Sclerotinia. MustGrow’s products are recognized as safe and are EPA- and PRMA-approved for use on fruits and vegetables.

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• SinglePoint is building an extensive portfolio of undervalued subsidiaries
• The company recently gave a shareholder overview detailing its new initiatives
• SinglePoint’s merchant services portfolio continues to grow

SinglePoint Inc. (OTCQB: SING) specializes in acquisitions of small to mid-sized firms and is focused on diversification into horizontal markets. The company’s emphasis is on new technologies, and its varied assets include payment processing, cannabis and more. Headquartered in Phoenix, Arizona, SinglePoint provides investors with an opportunity to gain exposure to a broad array of assets.

SinglePoint is building an impressive portfolio of undervalued subsidiaries that offer a varied holding base with multiple streams of revenue (http://ibn.fm/2Kov4). The company is taking advantage of its technological expertise to develop opportunities in the cannabis market, and, since 2014, SinglePoint has been providing ancillary solutions and investing in or acquiring businesses that provide services or offerings to the hemp and cannabis industries.

SinglePoint is eyeing opportunities to implement its payments expertise into accounts including CBD and cannabis clients. The company can support online and instore payments for business of all kinds and plans to continue alternative payments rollouts through the use of blockchain-based solutions.

Recently, SinglePoint provided a shareholder update overviewing its important growth initiatives. These initiatives involve solar, hemp and merchant services. The company’s most recent acquisition was that of Direct Solar, whose offerings span both commercial solar applications and renewable-energy financing options. Direct Solar enables residential solar customers to shop their options so that they can find the best offerings for their homes (http://ibn.fm/vw8gU).

Fundamentally, Direct Solar offers an innovative solution for lenders, building owners and management teams. For lenders, the firm provides verified projects with vetted services providers. Lenders offer Direct Solar their lists of requirements in order to fund a project. Subsequently, lenders receive only projects that fit within those parameters. For commercial customers, Direct Solar provides a one-stop shop where they can apply for and receive financing for their projects upon approval. In its first 60 days, Direct Solar contracted more than $3 million in residential solar contracts.

Furthermore, SinglePoint has its hemp-derived CBD (cannabidiol) offerings. SingleSeed is the company’s consumer-facing CBD brand, and it has been progressively building sales via its ecommerce site, SingleSeed.com. SingleSeed is now working on distribution agreements to bring hemp-derived CBD products to retail stores.

Moreover, SingleSeed is leveraging opportunities to manufacture products for consumers. Through its DIGS subsidiary, SingleSeed has leased a property in Carlsbad, California, to manufacture and distribute products ranging from hemp topicals to tinctures and capsules.

SinglePoint is also concentrating once again on payments and merchant services. The company is working to take on all kinds of businesses, including high-risk ventures such as cannabis and hemp, auto mechanic shops and restaurants. SinglePoint has acquired many new merchants recently and is currently building its strategy around bringing in more contractors to quickly scale its merchant services team.

SinglePoint continues to focus on its strategy to drive revenue growth through partnerships, equity-financed acquisitions and internal product development. The company offers investors a door to emerging technologies that have the potential for significant ROI, putting SinglePoint at the vanguard of innovation in new verticals.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

• MustGrow Biologics is building on positive results from testing of its mustard-based pest control product, with plans to develop a concentrated liquid form that it can market to the tobacco industry
• MustGrow’s focus on natural, safe and effective means of pest control positions it to meet the needs of the agricultural industry at a time when pesticide toxicity is an increasing concern to businesses and consumers
• MustGrow is also developing a suite of products that is expected to fill the organic pest control needs of the burgeoning cannabis industry

MustGrow Biologics Corp. (CSE: MGRO) is advancing its efforts to be a standard-bearer in the search for natural remedies to prevent pest damage in high value agricultural crops, including tobacco and cannabis, while news about chemical pesticide injuries continues to trouble the larger industry and its ancillary segments.

For years, MustGrow has been researching the effectiveness of organic mustard seed-based granules in fending off parasitic worms known as nematodes that harm tobacco industry productivity. These pests reduce statewide tobacco production by an estimated two percent each year in Virginia alone, according to a company news release (http://ibn.fm/QQPAO).

The company’s statement noted that the pre-plant granules resulted in significantly reduced nematode population density when applied at rates of more than 500 pounds per acre, and the findings are leading the company to develop a concentrated second-generation liquid formulation that could allow for lower usage amounts due to its higher concentration. As the new round of testing is completed on specific soilborne diseases, MustGrow intends to seek regulatory approvals for its formulation as an organic biopesticide that targets the needs of tobacco growers.

At the same time, MustGrow is hoping to expand on its fruit and vegetable pest control offerings by pulling together a suite of biological products from third parties, which the company aims to in-license and/or distribute for pests affecting licensed producers (LPs) in Canada’s burgeoning cannabis industry. Triangle Plant Science’s TP-1000, which improves nutrient effectiveness in plants to help them grow quicker and flower better, is the first third-party product adopted by MustGrow under its cannabis strategy. TP-1000 has shown its ability, in independent trials, to boost plant yield as well as terpene and THC levels, according to the company (http://ibn.fm/NHtDw).

The importance of improving defenses against nematodes was demonstrated when Bayer announced July 30 that it has canceled plans for broad distribution of its NemaStrike Technology amid ongoing concerns about rashes in a small number of people exposed to the pesticide or treated products, according to Reuters (http://ibn.fm/lByf3).

The Reuters report noted that Monsanto, which was acquired by Bayer last year, had planned to launch its “blockbuster” Environmental Protection Agency (EPA)-approved technology on up to eight million acres of crops in the United States during 2018, but called off the proposal following reports of rashing in some people.

An August 1 report on Brazil’s agricultural industry noted that the rising exporter is also beset by chemical pesticide concerns, with a potential international impact following the government’s adoption of a regulatory framework that identifies risk of death as the only criteria for determining how toxic pesticides may be labeled (http://ibn.fm/FkcEW). The change accompanies reports of increasing exposure to toxic pesticides among rural residents who live near fields.

MustGrow’s focus on only using safe, natural products that are scientifically shown to be effective alternatives to chemicals positions the company to fill genuine, life-sustaining needs from the agricultural industry. Its products have been tested on a commercial scale and carry minimal regulatory concerns, having already been granted approvals by the U.S. Environmental Protection Agency (EPA) and Canadian Pest Management Regulatory Agency (PMRA).

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• SGMD is commencing hemp cultivation by exercising an investment option in Hempistry Inc.
• Hempistry has a site in Madisonville, Hopkins County, Kentucky, where it is cultivating a fast-growing strain of hemp that’s rich in cannabidiol
• Hemp Business Journal reports that hemp generated more than $1 billion in revenues in the U.S. in 2018; the market is projected to reach $1.9 billion by 2022

Sugarmade Inc. (OTCQB: SGMD), a supplier of hydroponic and cultivation equipment to operators in the booming industrial hemp sector, has commenced hemp cultivation with Hempistry Inc. in Madison County, Kentucky. Sugarmade also announced that it is exercising its investment option in Hempistry as it intensifies its supplier and investor roles in the market (http://ibn.fm/C87U1).

Hempistry is cultivating a fast-growing strain of hemp that’s rich in cannabidiol. Although Sugarmade is not in the hemp cultivation business itself, the company has a business model focused on supporting and supplying hemp industry cultivators.

According to Hemp Business Journal, the hemp market in the Unites States was estimated to reach more than $1 billion in 2018, with growth forecasts calling for a 14.4 percent five-year CAGR to $1.9 billion through 2022 (http://ibn.fm/5XuiI). Hemp-derived CBD is projected to be the leading category of seven different sectors of hemp-based product sales by 2022.

Sugarmade CEO Jimmy Chan said in a news release (http://ibn.fm/6lk06) that SGMD has “multiple options for growth, while (its) recently effective S-1 filing expands (Sugarmade’s) ability to finance the many initiatives in front of the company.” SGMD is exploring the next generation of hemp-processing technology. The intersection of rising demand and the legal relief provided by the passage of the 2018 Farm Bill is expected to result in a peak industrial hemp crop in 2019. Hemp production is flourishing in Kentucky, as it leads the nation in quantity of cultivated acres, and SGMD’s commitment to the state is evident through its relationships with cultivators and suppliers like Hempistry and BZRTH.

Despite hemp’s current desirability in the United States, the crop has not always been so popular. It had been cultivated for its fibers for centuries before falling out of style in the 20th century, when it became entangled with efforts to criminalize drugs. As American businesses are getting into the hemp extraction market, they are finding themselves ill-equipped, lacking the advanced technology and expertise to produce on a large scale. Despite the industry’s dearth of technological advancement, Sugarmade has set itself up as an emerging leader in providing hemp extraction equipment. China has a more advanced hemp fiber industry, and SGMD has been working with Chinese extractors to usher in the newest technologies in hemp extraction (http://ibn.fm/pzI5b). The company now has the ability to supply high efficiency extraction equipment but is exclusively working with a limited number of ‘mega producers’.

Based in the Los Angeles-suburb of Monrovia, California, Sugarmade is a hydroponics and cultivation supply company that’s committed to supporting the industrial hemp sector. The company is also a product and brand marketing firm with numerous operations, such as packaging and paper goods for diverse industries.

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR